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ABSTRACT
The molecular basis of the potent transdermal enhancement activity of a series of
iminosulfuranes, structure provided where X = H, Cl, Br, and I, is being investigated skin
models.
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X = H, Cl, I, Br
It has been shown (J. Lipid Res. 46(2005), 2192-2201.) that correlations exist between
the activity of the aforementioned transdermal penetration enhancers (TPE) and the
extent to which these agents bind to DMPC vesicles and perturb the gel to liquid crystal
phase transition measured by calorimetry. The degree to which the perturbation of these
compounds extends into the bilayer interior in contrast to surface activity is unclear. To
gain insight into this issue, the 31P NMR resonance from DMPC and DMPC-cholesterol
unilamellar vesicles have been split by the slowly penetrating paramagnetic metal ion
Pr+3. The extent to which this perturbation is attenuated by transdermal penetration
enhancers has been investigated as a function of Pr+3 exposure time and iminosulfurane
concentration. The effect of these iminosulfuranes on bilayer integrity is also being

explored by monitoring the induced release of carboxyfluorescein from DMPC and
DMPC- cholesterol unilamellar vesicles.
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1. Introduction
Within the past decade, there has been an increase in the desire to administer drugs
transdermally. The advantage of transdermal administration includes elimination of the
first-pass effect by the liver, avoidance of the degradation of drugs by the gastrointestinal
tract, sustained and controlled release of drugs, and greater compliance from patients.
The skin provides an effective barrier to water loss, protects the body from unwanted
influences, and prevents the permeation of environmental substances and the entrance of
foreign material into the body. This barrier function of the skin is an obstacle to be
overcome by transdermal drug delivery. In order to effectively utilize the possibilities
created by the use of topically applied drugs, it becomes necessary to understand the
nature of skin and mechanisms or other substances that could control the extent of its
barrier function. Controlling the barrier function of skin topically would allow medicines
to permeate the skin and access the blood supply allowing for systemic delivery of drugs.
The advantages of this type of drug delivery include targeting specific areas of the body
and decreasing the amount of drug necessary for effect as compared to drugs taken orally.
1.1. Structure of Skin and Its Barrier Function
Skin, the largest organ of the body is composed of several layers including the
epidermis and dermis (Figure 1-1). Its thickness is typically 0.1- 1.0 mm, depending on
location in the body. The dermis is the largest part of the skin and serves as a means of
protection for the underlying organs and provides nutrient necessary for the growth and
differentiation of the cells in the epidermis. The epidermis is separated from the dermis
by a basale membrane. In the first two layers of epidermis skin cells are synthesized and
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in the remaining layers the cells undergo transitions to finally become the
characteristically flat corneocytes embedded in a lipid bilayer found in the stratum
corneum (SC). The one cell thick layer just above the basale membrane is the stratum
basale. In this layer, epidermal stem cells undergo cell division and begin the slow 2 -3
week journey through the higher epidermal layers until reaching the surface layer. The
stratum spinosum, the next layer of the epidermis, is typically 2-7 cells thick with
polyhedral shaped cells.1 These preformed stratum corneum cells are present with
enzymes.2 The phospholipids in the cell membranes are degraded into glycerol and free
fatty acids, whereas the glycosylceramides are degraded into ceramides.3 In the transition
from stratum spinosum to the stratum granulosum, the organelles are formed in the
endoplasmic reticulum and are expelled into the extracellular space surrounding the
cells.2 The stratum granulosum consists of 2-3 layers of diamond-shaped cells. The
cytoplasm of these cells looks like thick granules corresponding to the name of this layer.
These thick granules are the precursors for the corneocytes located in the SC.2 In this
layer, the majority of the keratin, a structural protein, is produced. In the next thin single
layer of cells known as stratum lucidum, the cells lose their nuclei and cell organelles. As
the epidermal cells transition to the final layer, the volume of the intercellular space
increases from 2 cell layers to 15 layers. The outer layer of the epidermis is the stratum
corneum (SC), also known as the horny layer, and contains 10-30 layers of flattened
hexagonal dead skin cells where the number of layers depends on the skin location. For
example, the skin on the abdomen has a thinner SC with fewer layers of dead skin cells
than those found on the bottom of feet. This layer provides the main barrier function of
the skin and is typically 0.01 mm, at most 10 percent of the total thickness of skin. The
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stratum corneum is a composed of keratinized cells in a lipid bilayer. The bilayer is
composed of a milieu of at least six different ceramides with differing head groups and
fatty acid chain lengths, free fatty acids (FFA) with greater than 20 carbons, cholesterol,
and cholesterol sulfates.3 The structure is most commonly compared to a brick wall,
hence the structure is described by a “brick and mortar model” as shown in Figure 1-2.
The bricks in the wall represent the corneocytes or dead skin cells. The mortar in between
the bricks is a lipid bilayer composed of a mixture of ceramides, free fatty acids,
cholesterol, and cholesterol sulfate. Perturbation of the stratum corneum usually results
in a metabolic response that restores the barrier function and limits the bioavailability of
drugs administered transdermally.4
There are three primary routes of entry into the stratum corneum which include the
movement of molecules via the sebaceous glands of hair follicles, across the stratum
corneum or by way of the sweat glands.5 Movement of molecules through an intact SC
can be subdivided into two possible routes of entry, transcellular and intercellular.5 As
illustrated in Figure 1-3, the transcellular route involves the movement of drugs across
alternating layers of corneocytes and lipid bilayer in order to reach viable tissue. The
intercellular and most likely route of permeation into the SC and eventually to the blood
supply is through the lipid matrix that surrounds the corneocytes. This disruption could
occur through mechanisms such as compounds intercalating into the lipid bilayer or
modifying the inherent solubility of skin lipids thereby allowing drugs to penetrate the
SC that would normally be unable to overcome the barrier function.6 A significant effort
has been applied to understanding the mechanism through which topically applied drugs
can interact with the intercellular bilayer and ultimately overcome the barrier function of
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the skin. Realistically, there are very few drugs available that have a high enough
permeability coefficient to permeate an intact SC via passive strategies. These drugs are
effective at low doses, have relatively small molar masses (< 400 Da) and are lipophilic.7
There are few drugs that meet these qualifications. As a result, passive transdermal drug
delivery is limited to cardiovascular, hormone replacement, contraception, smoking, pain,
and motion sickness treatment.

8

Therefore, there is a need for a method of enhancing

drug delivery to the viable cells located beneath the SC. From this need arose a method
known as transdermal penetration enhancement.
1.2. Transdermal Penetration Enhancers
Several techniques have been developed to facilitate the movement of drugs across
the SC and enhance transdermal drug delivery. There are five classifications of methods
for improving delivery: drug or vehicle interactions, vesicles and particles, removal or
bypass of the SC, electrically assisted methods and modification of the SC.5 Drug or
vehicle interactions involve changing the flux of the drug (Equation 1-1) where flux is
dm/dt. If the vehicle of the drug is volatile, upon its evaporation it leaves a supersaturated
solution of the drug in a thermodynamic state such that it has a flux greater than one
milligram per hour and can overcome the barrier function of the SC.5

5

dm DCoK
=
dt
h
Equation 1-1 Steady-State flux.5
dm/dt is the cumulative mass of pass a unit area of membrane per unit of time.
D is the diffusion coefficient.
Co is the donor drug concentration.
K represents the partition coefficient of the solute that exists between membrane and
bathing solution.
h is the thickness of the membrane.
Another drug vehicle interaction is one in which a vehicle permeates the skin first and
“drags” the drug through the skin.5 The use of prodrugs involves molecules that only
become biologically active after enzymes generate the active forms. 8 Finally, the vehicle
can increase the solubility of the drug.5
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Figure 1-1 Structure of the Skin.9
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Figure 1-2 “Brick and Mortar” model of the stratum corneum.10
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Figure1-3 Stratum corneum and two routes of drug penetration.5
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Another classification of transdermal penetration involves bypassing or removing the
SC. The SC can be bypassed using injections below the horny layer or via the hair
follicles in the SC. Recent developments have created the resurgence of this technique
that had been abandoned after the realization that the use of tiny needles caused skin
damage. Adaptations of this concept include the use of hundreds of microneedles that are
coated with the drug or contain the drug to be injected.5 This method enhances
transdermal drug delivery five times. Follicular delivery involves the use of colloidal
particles to introduce drugs into the epidermis via the hair follicles. 5The SC can be
removed by chemical peels, dermabrasions, microdermabrasions, and adhesive tape
stripping.11
Electrically assisted methods of transdermal penetration enhancement include
iontophoresis,

ultrasound,

electroporation,

magentophoresis,

radio

waves

and

photomechanical waves. Iontophoresis uses a low electric field to create a potential
gradient across the membrane in order to transfer charged drugs and most recently neutral
and zwitterionic drugs across the SC.12 The success of iontophoresis is limited by the size
of the drug. Some drugs are also able to overcome the barrier of the SC by ultrasound
techniques known as sonophoresis or phonophoresis. Ultrasound is vibration at
frequencies beyond the human audible range. The force of these sonic waves can increase
the fluidity of the SC lipids or the drugs, apply pressure and force molecules through the
skin, or perturb the SC lipids to facilitate the movement of drugs across the skin barrier
1000 times greater than normal flux in absence of the sound waves.13 In a similar manner
short high voltage electric pulses produce aqueous pathways across the lipid bilayer in an
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application known as electroporation.7 Electroporation produces transient pores and
enables larger molecules than the aforementioned iontophoresis.
The final method of transdermal penetration and focus of this dissertation is the
alteration of the SC via hydration or chemical penetration enhancers. A class of enabling
compounds has been targeted to the stratum corneum to allow substances to cross the
skin barrier. These compounds are known as transdermal penetration enhancers (TPEs)
and enhance the skin penetration of drugs via solvation, interaction with the polar head
groups of bilayers, disruption of lateral bilayer packing, inducing transitions in the
lamellar phases, or protein-lipid interactions.4 These compounds must be able to
reversibly disrupt skin barrier function, be active at low concentrations, be nontoxic, and
non-irritating. Finally, they must be soluble in nontoxic, non-irritating media. A variety
of different compounds meet these qualifications including water, hydrocarbons,
pyrrolidones, fatty acids, esters, alcohols, surfactants, amides, polyols, terpenes,
oxazolidines, enzymes, polymers, inhibitors of lipid synthesis, azone and its derivatives,
sulfoxides and their analogs, and synergistic mixtures of any of the aforementioned
compounds (Figure 1-4).5
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Figure 1-4 Representative structures of transdermal penetration enhancers.
R is any alkyl group.

12
The action of these compounds can be subdivided into three main avenues, lipid
action, protein alteration and promotion of partitioning of drugs (Figure 1-5). Lipid action
is a result of fluidization, phase separation, polarity alteration and lipid extraction.8
Fluidization occurs when hydrophobic lipid enhancers insert in between the hydrophobic
tails of the lipids or polar enhancers interact with the polar head groups of the lipids and
alter the highly organized structure of the lipid matrix in the SC making the bilayer more
fluid. In phase separation TPEs, either create a water pool or form an inverted micelle in
the multilayer lipid matrix. Polarity alteration, another lipid interaction of TPEs, occurs
when the presence of the enhancers induces repulsion between neighboring lipid
molecules. This repulsion disrupts the packing of the lipids and allows drugs to overcome
the barrier function of the SC. Finally, lipids can be extracted from the bilayer to create a
less dense lipid matrix.

Protein alteration can be a function of an enhancer interacting

with protein structures and splitting the SC, thus removing the densely packed nature of
the SC or denaturing the keratin found in the corneocytes and creating vacuoles
introducing a less restrictive entry point for drugs.8 Promotion of drug partitioning
involves the use of enhancers to increase the flux of a drug across the SC. The
mechanism of action for many effective transdermal penetration enhancers involves more
than one mechanism.
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Figure 1-5 Possible mechamisms of action for chemical penetration enhancers. 8
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Water is continuously present in the skin and maintained at constant levels. The SC
can hold three-five times its mass in water.14 The action of skin hydration is two-fold.
The presence of water alters the homeostatic gradient and allows for the increase in flux
of polar molecules. Secondly, hydrating the skin raises the temperature of the site and
swells the corneocytes; as a result the SC is less compact and drugs cross the SC more
easily.14 Pyrrolidines and their derivatives are heterocyclic amides. At low
concentrations, pyrrolidones denature the keratin in the corneocytes; where as at higher
concentrations, they increase water content and increase fluidity of the lipid matrix.15
Alkyl pyrrolidines are known to intercalate in the SC lipid bilayer, thus creating greater
fluidity in the bilayer.16 Fatty acids disrupt the packing of the lipid bilayer and increase
the permeability of SC. Additionally, some fatty acids act as solvent in the SC: as the
fatty acid enters the SC, drugs with a high affinity for the fatty acids are dragged into the
SC.17 Alcohols have been observed to be most effective in enhancing penetration of the
SC when the chain length is between 10-12 carbons.18 Based on these observations and
the fact that the carbon chain on the most effective alcohols is similar to the length of the
carbon chain on steroid nucleus of cholesterol, it is thought that the penetration
enhancement is from the interaction of alcohols with the ceramide–cholesterol or
cholesterol-cholesterol interactions in the SC.18 Both fatty acids and alcohols enhance
transdermal penetration by disordering packing arrangement of SC lipid matrix and
creating aqueous pores, and by forming complexes with drugs and making them more
lipophilic.

15
There are four types of surfactants: cationic, anionic, nonionic, and zwitterionic. The
use of surfactants is limited because most irritate the skin causing tightness, inflammation
and erythema.19 Cationic surfactants are the most damaging to the skin followed by
anionic surfactants which are intermediate and nonionic surfactants which are the least
irritating. There are two mechanisms of action attributed to charged surfactants,
interaction with SC proteins, and extraction of SC lipids by micelle solubilization.
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Nonionic surfactants result in the least amount of damage to the SC. Consequently, their
ability to serve as penetration enhancers is limited. However, nonionics can be used in
conjunction with charged surfactants by forming mixed micelles and limiting the
deleterious effect of cationic and anionic surfactants.19

Urea is an amide that is an

effective transdermal penetration enhancer. Its mechanisms of action include serving as a
moisturizer by increasing water content and lowering the phase transition of the lipid
bilayers, thus allowing drugs to permeate the SC more easily.20 Long exposure time to
urea breaks down the keratin.20 Terpenes are naturally occurring compounds made of
varying arrangements and numbers of isoprene units. The differing structures of terpenes
work well with different drugs. However, terpenes disrupt the lipid matrix in the SC,
interact with the SC proteins and improve partitioning of drugs.21 Azone® (1dodecylazacycloheptan-2-one),

a

TPE

currently

in

clinical

trials,

distributes

homogeneously through the SC lipid matrix and as suggested by molecular modeling, the
polar lactam group may force apart the polar head groups in the SC lipid matrix to
increase membrane fluidity.22, 23 Some silicone polymers act as penetration enhancers by
increasing the hydrophobicity of the skin surface and in doing so influence the
partitioning of hydrophobic drugs into the SC.24 Dimethyl sulfoxide is has been widely
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used in the medical field since the 1960’s. 25 It has a high dielectric constant because the
polarity of the sulfur and oxygen bond. At low concentrations, DMSO denatures the
proteins in the corneocytes and promotes swelling by displacing the water in the interior
of the corneocytes. DMSO is most effective at concentrations greater than 60 percent.25
At these concentrations, DMSO interacts with the polar head groups of the lipid matrix
by displacing surrounding water molecules. As a result, channels form in the multilayer
lipids of the SC.25 A series of iminosulfuranes isoelectronic with the sulfoxide group in
DMSO (Figure 1-5), where X = H, Cl, Br, and I has been shown to function as potent
TPEs in human cadaver and hairless mouse skin. However the mechanism of action is not
understood. 26, 27
1.3. Biological Data of Iminosulfuranes
Since iminosulfuranes are isoelectronic with the sulfoxide group of DMSO, these
iminosulfuranes were screened to determine whether their biological activity is similar to
that of DMSO.26 These compounds were initially screened using hairless mouse skin, a
highly permeable skin model.28 If the iminosulfuranes proved active in the mouse skin, it
could be an indication that these compounds would be active in human skin. Several
parameters were measured in the mouse skin. Two of those parameters to be discussed
are ERJ and Q24. ERJ is the ratio of hydrocortisone flux across skin samples in the
presence of selected iminosulfuranes to the flux value observed in control experiments.
Q24 is the amount of hydrocortisone that passes through the skin in 24 hours. The results
are summarized in Table 1.
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Table 1-1 Permeation parameters of hydrocortisone on hairless mouse skin.23, 28
Substituents
Control
DMSO
H
Cl
I
Br

ERJ
1.00
1.37
0.88
1.51
1.6
21

Q24 (µg/cm2)
43.1 ± 5.2
45.5 ± 12.1
32.1 ± 10
61.9 ± 12.1
121 ± 24
996 ± 192

Based on the results DMSO does not appear to have significant activity in comparison to
the control. The iodo and chloro derivatives exhibit similar activity to DMSO. The
bromo derivative shows activity similar to Azone®, a transdermal penetration enhancer,
that is currently used in clinical trials.28
Since the bromo and iodo derivatives were the most active compounds in the
series of iminosulfuranes tested, further studies were conducted to determine whether the
activity would be extended to human cadaver skin.23 Permeation measurements of
hydrocortisone, in the presence of iminosulfurane derivatives, flux and Q24, are shown in
Table 2 and support the permeation studies conducted using hairless mouse skin.
Table 1-2 Permeation parameters of hydrocortisone on cadaver skin. 23
Substituents

ERJ

Q24 (µg/cm2)

Control

1

22.1 ± 5.1

Br

17.0

319.7 ± 24.6

I

0.8

26.0 ± 3.9
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The permeation of the hydrocortisone in the presence of 0.4 M bromo derivative is
significantly higher than in its absence or in the presence of the iodo derivative.
Additionally, as concentration of the bromo derivative increases from 0.0 M to 0.4 M,
there is a significant increase of the flux of hydrocortisone and caffeine and the amount
of hydrocortisone and caffeine present increases over 24 hours.23
Because TPEs are known to cause skin irritation, cytotoxicity studies of the iodo and
bromo derivative were performed on epidermal keratinocytes and dermoblasts. Cell
viability for both the keratinocytes and the dermoblasts showed a decrease in viability
with increasing concentrations of iminosulfuranes; however at concentrations less than
0.2 M, there was no statistically significant effect on cell viability.23 In contrast at
concentrations between 0.7 M and 0.9 M, there was a 50 percent decrease in cell
viability; therefore ideal concentrations for the use of these TPEs would be less than 0.2
M.
1.4. Phospholipids as Models for Skin
The barrier function of skin resides in the SC which consists of keratin filled dead
cells surrounded by a crystalline lamellar lipid. Because the corneocytes are so dense, it is
unlikely that TP’s applied to the surface of the skin will be able to diffuse through the
dense protein structures. Consequently, the most likely route of entry is through the lipid
regions surrounding the corneocytes. In order to develop a model system for lipid matrix
for the purpose of observing the effect of TPEs on such models, it is necessary to
understand the nature of the lipids in the SC and make comparisons to the particular
models of choice (DMPC and DMPC-cholesterol liposomes).
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The lipid matrix is composed of at least nine different ceramides with lengths varying
from 16-33 carbons, cholesterol, and free fatty acids most commonly containing 22 and
24 carbons.3, 29 Ceramides are amphipathic molecules and are capable of forming stable
bilayers in the presence of cholesterol and either a free fatty acid or cholesteryl sulfate.30
The lipids in the SC form the traditional multilamellar bilayers. Freeze fracture electron
microscope studies of human SC show that the lamellar phase has two components, one
with a periodicity of 13 nm and the other with a periodicity of 6 nm.31 Diffraction
patterns show that the lateral packing in absence of FFA is hexagonal. However,when
FFA is added, the lateral packing changes to orthorhombic. Since orthorhombic packing
is more densely packed than hexagonal, the barrier function of SC is supported by the
presence of FFA.31

The chain lengths of ceramides are longer than those of

phospholipids typically used in liposomes. Additionally, the head groups of ceramides
are small in comparison to those of phospholipids and contain different functional groups
such as amides and hydroxyls. Consequently, they are capable of forming intermolecular
and intramolecular hydrogen bonds which lends to the difference in the structure of the
lipid matrix found in SC and that of phospholipids.31 Additionally, it has been shown that
mixtures of SC lipids can be used to prepare small unilamellar vesicles in a similar way
to phospholipid SUV’s.30
While they are little to no phospholipids present in the SC lipid matrix, phospholipid
bilayers provide a useful means of investigating the molecular mechanisms responsible
for the activity of transdermal penetration enhancers. Phospholipids are the simplest
models that approximate some of the properties of a biological membrane. They
structurally resemble bilayers, have a similar thickness and water permeability, as well as
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exhibiting similar bending rigidity, surface tension, and viscosity. DMPC, a synthetic
lipid, is often used because it undergoes phase transition at a convenient temperature
(23.6°C). In a model skin system consisting of DMPC unilamellar vesicles, it has been
shown that correlations exist between the biological activity of the aforementioned
transdermal penetration enhancers (TPE) and the extent to which these agents bind to
DMPC vesicles and perturb the gel to liquid crystal phase transition measured by
calorimetry.27
1.5. Role of Cholesterol
Cholesterol is an amphiphilic lipid whose structure differs greatly from that of
phospholipids and ceramides. The hydrophobic portion of cholesterol is the steroid
nucleus which consists of three cyclohexane rings and one cyclopentane ring. The
hydroxyl group on the ring serves as the polar head of molecule. Therefore, cholesterol is
classified as a lipid with a bulky, stiff hydrophobic tail and a small hydrophilic head.32
Cholesterol is present in all mammalian cell membranes and is known to order bilayers.
The presence of cholesterol in phospholipids induces a change in the morphology of the
bilayer that is different from liquid-crystalline state or gel state and produces a new phase
described as a liquid–ordered state.33 In a liquid-crystalline lamellar state, the
phospholipids form a bilayer. However their motion has liquid-like properties.

In

contrast, the lipid hydrocarbon chains in the gel state are extended and tilted slightly to
allow for tight packing. Because of the tight packing, there is limited rotation of the
hydrocarbons and there is a limited number of water molecules bound to the polar
headgroups. The liquid ordered phase is characterized when the rigid steroid nucleus of
cholesterol is located in the top portion of the hydrocarbon tail of the phospholipid and
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the hydrocarbon tail of cholesterol is in the more disordered part of the bilayer. The
cholesterol orders the hydrocarbon tail deep within the bilayer and limits their
isomerizations. As a result, there a fewer kinks in the phospholipid bilayer (< 18 carbons)
and the width of the bilayer increases.33 The ordering of the lipids also limits the
permeability of molecules through the bilayer. In systems without cholesterol, the
disordered kinks produce regions of packing defects. It is through the local regions of
defects that small molecules are able to permeate the bilayer. Finally cholesterol in the
bilayer decreases the surface area of phospholipids at the interface of water and interferes
with the hydrogen bonding or weak electrostatic interactions that occur between
phosphate groups of individual phospholipids.33
Johnson et al. have shown that there is a correlation between the flux of small (< 500
Da) lipophilic compounds across SC lipids and DMPC and DMPC/cholesterol bilayers
where the concentration of cholesterol is 40 mole percent.

34

Based on the compounds

evaluated, it was shown that the DMPC and DMPC/cholesterol models exhibited the
same qualitative effects. However, there was a departure in the quantitative analysis of
the lateral diffusion coefficients in the models. In the DMPC model, the observed
diffusion coefficients for the small molecules differed 15-fold from the SC lipid model.34
There was less of a departure in diffusion coefficients of DMPC/ 40 mole percent
cholesterol model compared to SC lipids in that there was only a 3-fold difference.34
Consequently, DMPC and DMPC/cholesterol preparations can provide useful qualitative
information about the effect of iminosulfurane derivatives on the membrane integrity. For
quantitative results more information can be obtained from DMPC/cholesterol bilayers
than from DMPC alone.
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1.6. Effect of Iminosulfuranes on Bilayer Integrity
In order to understand the structure and phase behavior of lipid bilayers in the
presence of transdermal penetration enhancers, more specifically the derivatives of
iminosulfuranes, there are commonly used physicochemical principles such as those
employed by differential scanning calorimetry (DSC), isothermal titration calorimetry
(ITC), nuclear magnetic resonance (NMR), fluorescence, x-ray diffraction, and infrared
(IR). Because lipids form highly organized structures when they are hydrated, their
structures are dependent on various conditions such as temperature, pH, pressure, and the
presence of perturbing compounds. DSC is a useful technique for determining the lipid
phase transitions of membrane lipids.

The principle upon which it operates is the

comparison between a sample and an inert reference heated linearly with time. Typically,
the sample is a suspension of vesicles in solvent and the inert reference is water or buffer.
As long as the lipid does not undergo a phase transition, there in no temperature change
and the temperature differential is zero. Once the lipid undergoes a physical
conformational change such as a phase transition, there is a temperature differential
between the two samples; consequently the instrument changes either the power input or
the rate of heat flow to eliminate the differential.35 After the phase transition is complete,
the baseline reestablishes.
It has been shown that correlations exist between the activity of the
aforementioned transdermal penetration enhancers (TPE) and the extent to which these
agents bind to DMPC vesicles and perturb the gel to liquid crystal phase transition
measured by calorimetry. DMPC liposomes undergo two phase transitions, pretransition
and main phase transition. Pretransition is characterized by transition of the lipid bilayer
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from gel to ripple layer organization, where chain packing changes from a distorted
orthorhombic to a hexagonal lattice.35 The main phase transition occurs when the lipid
organization changes from ripple to fluid. Barrow et al. report the effect of 10 mole
percent of iminosulfuranes on the pretransition and main phase transitions.
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The

pretransition peak broadens in the presence of 10 mole percent TPEs, which could
indicate that they interact with the polar head groups supporting a surface interaction.27
The bromo derivative of the iminosulfurane caused a shoulder to appear before the main
phase transition of DMPC, which could support the destabilization of the DMPC
bilayer.27 The introduction of the bromo derivative into a solution flowing over a DMPC
bilayer deposited on a gold support in measurements based on the evanescent wave
technique lead to the loss of bilayer mass, suggesting this TPE induced surface
degradation of the bilayer had occurred (personal communication).

These findings

indicate that the iminosulfuranes act through surface dependent interactions. However
other results to be discussed support more than surface interaction involvement.
Strong nuclear overhauser effect (NOE) cross peaks between the DMPC surfacelocated choline N(CH3)3 moiety protons and the phenyl group protons of the TPEs are
also observed.27 These data suggest that bilayer surface effects may contribute
significantly to the mode of action of the compounds. However, previously reported data
demonstrate that a NOESY cross peak appears between the terminal methyl of the lipid
fatty acid and the phenyl protons of the bromo iminosulfurane. This cross peak suggests
that the bromo derivative of the iminosulfurane deeply penetrates into the lipid bilayer
causing the phenyl protons to be near the termini of the alkyl chains of DMPC bilayer.
However, an alternative interpretation of this NOESY cross peak is that the alkyl chains
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of lipids undergo a low-probability bending in vesicles causing the terminal methyl
groups to be near the vesicle surface.36 In view of these observations, 31P NMR has been
employed to evaluate whether the activity of the iminosulfuranes described in Figure 1-1
is dependant on their deep penetration into the DMPC and the DMPC-cholesterol bilayers
and by extension into the skin. The degree to which the perturbation of these compounds
extends into the bilayer interior in contrast to surface activity is unclear. 27
Carboxyfluorescein is a fluorophore that undergoes self-quenching at high
concentrations (100 mM) via the formation of dimers. Once the interior of the vesicle
contained the fluorophore in excess of the threshold quenching concentration, vesicles
exhibited minimal fluorescence. If the addition of a TPE to the vesicle suspension
disturbs the integrity of the bilayer, the carboxyfluorescein is released in a monomer
fluorescent form. The release CF is expected to correlate with the perturbation of the
bilayer. Therefore, the effects of these iminosulfuranes on bilayer integrity of DMPC and
DMPC-cholesterol liposomes have been characterized using fluorescence spectroscopy.
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2. Materials and Methods
2.1. Materials and Methods for DMPC Preparations
2.1.1. Materials
Synthetic L-α-1,2-dimyristol-sn-glycero-3-phosphocholine (DMPC) was obtained
from Avanti Polar Lipids, Alabaster, Alabama. Potassium chloride, reagent grade was
purchased from Baker & Adamson Company, and N-[2-hydroxyethyl]piperazine-N׳-[2ethanesulfonic acid] (HEPES) and cholesterol, 99 percent purity, were obtained from the
Sigma Chemical, St Louis, Missouri. Ethylene diamine tetraacetic acid (EDTA) and
Methanol, Optima purity, were obtained from Fisher Scientific, Fair Lawn, New Jersey.
Chloroform, OmniSolv grade, was obtained from EM Science, Gibbstown, New Jersey.
Deuterium oxide was obtained from the Aldrich Chemical Company. Halogenated
iminosulfuranes were synthesized by the research group of Professor L. Strekowski.28
2.1.2. Vesicle Preparation
Small unilamellar vesicles were prepared by rehydrating DMPC with 10 mM
HEPES buffer with 160 mM potassium chloride and 0.8 mM EDTA at pH = 7.5 and
used to prepare vesicles by the technique of Bammel et al.37 The 9 mM suspension was
premixed for 5 minutes and sonicated for 40 minutes (40 percent duty cycle) at 35 ºC
under a stream of nitrogen. The resulting solution was centrifuged at 130,000 at 35 ºC to
remove particulate matter. The supernatant was retained and stored in the oven at 35 ºC.
This method produces nominally 300 Å – diameter unilamellar vesicles.
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2.1.3. Preparation of 31P NMR Samples
The 31P NMR spectra were obtained at 202 MHz at 35ºC using proton decoupling
and a pulse width of 16.5 µs and acquisition time of 0.800 s. The free induction decays
were obtained with 6000 transients and a relaxation delay time of 2.0 s and 150 Hz line
broadening factor. The spectra were recorded using a Varian Inova 500 MHz Fourier
Transform spectrometer. The magnetic field strength was locked to an internal deuterium
standard, consisting of 10 percent by volume deuterium oxide that was added to the
supernatant retained after vesicle preparation. Probe temperature was 35 °C. All peak
shifts were referenced to an external standard of 10 percent by volume of
trimethylphosphate and 10 percent by volume of deuterium oxide in 10 mM HEPES
buffer with 160 mM potassium chloride and 0.8 mM EDTA at a pH = 7.5. An initial 31P
NMR spectrum was acquired without the addition of the Pr3+ shift reagent. After
obtaining the spectrum of the unilamellar vesicle solution without the shift reagent, 4.5
mM Pr3+ was added to the sample. The spectrum was again recorded after maximum
resonance separation was achieved, nominally after 18 h, and 10 mole percent
iminosulfurane was then added to the sample, after which the spectrum was monitored
over an additional 66 h. All spectra were recorded in triplicate unless otherwise noted.
2.1.4. Preparation of Iminosulfurane Solutions
Three millimolar solutions of iminosulfuranes were prepared in HEPES buffer (160
mM KCl and 10 mM HEPES) by adding no more than 4 percent ethanol to aid in
dissolution of the iminosulfuranes.
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2.2. Materials and Methods for 31P NMR: Iminosulfuranes and DMPC and
Cholesterol Preparations
2.2.1. Materials
Cholesterol, 99 percent purity, was obtained from Sigma Chemical, St Louis,
Missouri. The remaining materials utilized are described in section 2.1.1.
2.2.2. Vesicle Preparation
DMPC and cholesterol present at 16 mole percent and 30 mole percent were
dissolved in chloroform/methanol 2:1 by volume mixing. The phospholipids mixture was
dried by rotary evaporation to a thin film. The resulting thin film was placed under high
vacuum overnight to further evaporate any additional solvent. Dried films were stored at
0 ºC under vacuum. The dried films were rehydrated with 10 mM HEPES buffer in
160 mM potassium chloride at pH = 7.5 and used to prepare vesicles by the technique
described in section 2.1.2.
2.2.3. Preparation of 31P NMR Samples
Samples were prepared as described in section 2.1.3. without EDTA.
2.3. Materials and Methods for Carboxyfluorescein Preparations
2.3.1. Materials
A mixture of isomers of (5)-and(-6)-carboxyfluorescein (CF) was purchased from
Molecular Probes and purified before use. Cholesterol, 99 percent purity, Sephadex G-50
and Sephadex LH-20 were obtained from Sigma Chemical, St Louis, Missouri. Triton X100, electrophoresis grade was obtained from Fisher Scientific, Fair Lawn, New Jersey.
Additional materials are referenced in section 2.1.1.
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2.3.2. Purification of Carboxyfluorescein
In order to the prepare carboxyfluorescein liposomes, the CF was recrystallized
and purified according to a protocol written by Zuidam et al.38 In order to remove the
polar contaminants, CF was dissolved in ethanol and boiled with activated charcoal in a
water bath. The charcoal was filtered and the resultant solution was recrystallized with
the addition of ice cold water and cooled slowly at -20 ºC overnight. The precipitate was
dried with a Büchner funnel and then in a vacuum dessicator.38
To remove the hydrophobic contaminants, a 2 M solution was prepared with the
previously purified CF by dissolving the CF in NaOH and adjusting the pH to 7.5 by the
addition of 6 M HCl while heating the solution to 50 ºC to aid in dissolution. The
resultant solution was placed on a Sephadex LH-20 hydrophobic column (2.5 x 40 cm).
The sample was eluted using HEPES buffer (10 mM HEPES, 160 mM potassium
chloride and 0.8 mM EDTA). Hydrophobic impurities remained on the top of the column
as a nonfluorescent residue. The purity of the collected fractions was examined using
silica gel thin layer chromatography with a solvent system of chloroform, methanol, and
water with a by volume ratio of 65:25:4. The pure fractions were pooled and adjusted to
the 100 mM for liposome preparation. The concentration of the pooled fractions was
determined by measuring the absorbance at 492 nm, since the molar extinction
coefficient of CF is 75,000 M-1 cm-1 at 492 nm.38 All absorbance measurements were
made using a CARY 3G UV-visible spectrophotometer.
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2.3.3. Calibration Curve and Self-Quenching Measurements of
Carboxyfluorescein
A set of standard dilutions was prepared from a 0.057 mM stock solution of
carboxyfluorescein in HEPES buffer. Sequential tenfold dilutions were made
concentrations and the fluorescence of the resulting solutions was measured using a using
a Photon Technology Instrumentation QuantaMasterTM Spectrofluorometer. The same
stock solution was used to prepare test solutions for assessing the range in which CF selfquenches. Data were recorded using FeliXTM software. The excitation wavelength was
460 nm and emission was scanned from 480- 650 nm at a 2 nm spectral bandwidth and 1
nm step size with a 1 s integration time.
2.3.4. Stern-Volmer Analysis
Solutions of carboxyfluorescein were injected with variable amounts of bromo
and iodo derivative using a Hamilton syringe. The fluorescence was recorded using a
Photon Technology Instrumentation QuantaMasterTM Spectrofluorometer. Data were
processed using FeliXTM software. The fluorescence emission of CF was recorded at 523
nm (λex = 492 nm).
2.3.5. Preparation of Vesicles with CF
Vesicles encapsulated with carboxyfluorescein were prepared as described in
section 2.1.2 and shown in Figure 2-1. However; the DMPC and DMPC-cholesterol
preparations were suspended in a 100 mM CF solution prior to sonication.
Unencapsulated CF was removed using a Sephadex G-50 (2.5 x 40 cm) water jacketed
column equilibrated with HEPES buffer and pre-saturated with CF-free vesicles made
from DMPC and DMPC-cholesterol depending upon the lipid used to encapsulate the CF.
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The vesicles were eluted using HEPES buffer (10 mM HEPES, 160 mM potassium
chloride and 0.8 mM EDTA).
2.3.6. Electron Microscopy
The electron micrographs were obtained using a JEOL 100CX-II Transmission
Electron Microscope. Ten microliters of the vesicle suspension were placed on a nickel
formvar coated grid and allowed to sit for one minute. The excess suspension was
removed with filter paper. The remaining sample was negatively stained with 1 percent
uranyl acetate.
2.3.7. Determination of CF Release from Vesicles
The release of CF was used to measure the integrity of the bilayer. Fluorescence
intensities were obtained with a Photon Technology Instrumentation QuantaMasterTM
Spectrofluorometer maintained at 35°C. Data were processed using FeliXTM software.
The fluorescence emission of CF was recorded at 523 nm (λex = 492 nm) at a 2 nm
spectral bandwidth and 1 nm step size with a 1 s integration time. Measurements were
taken in one second intervals. 100 µL of vesicles encapsulated with CF was combined
with varying concentrations and diluted to total volume of 2.2 ml with HEPES buffer (10
mM HEPES and 160 mM potassium chloride). The emission fluorescence intensity was
measured before and after the addition of 20 percent v/v Triton X-100 for a final
concentration of 1 percent.

R(t) = I(t ) − I(0 ) x 100
I(∞ ) - I(0 )

Equation 2-1 Equation for the percent release of CF.
R(t) is the percentage of CF released. I(t) is fluorescence intensity at time t. I(0) is initial
fluorescence intensity and I(∞) is maximum fluorescence intensity.
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Figure 2-1 Scheme for the preparation of carboxyfluorescein liposomes.
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3. Results
3.1. Interaction of Bromo Derivatives with DMPC Liposomes
Figure 3-1 illustrates the effect of bromo iminosulfurane derivative on DMPC
liposomes hydrated in HEPES buffer containing EDTA. The data were fit by linear
regression. Peaks shifts were referenced to an external trimethylphosphate standard in
HEPES buffer with EDTA (see the Materials and Methods section 2.1.3). In DMPC
vesicles containing no cholesterol, the bromo derivative decreases the 31P resonance
separation at a rate that is only marginally greater than that due to vesicle aging
(Figure 3-1).

At 0.1 mole percent, the bromo derivative appears to inhibit the

reduction due to the normal aging as observed in the control. The vesicles do exhibit
an aging effect. However, when the bromo derivative concentration is 0.2 mole
percent or greater, the peak separation decay rate is greater than the decay of the
vesicles alone. A plot of the slopes from the regression fit is plotted versus mole
percent (Figure 3-2). At 5 and 10 mole percent, there is a significant difference in
the slopes, indicating an increase in the decay of peak separation in the presence of
bromo iminosulfuranes at these concentrations.
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Interaction of Varying Concentrations of Bromo Derivatives with DPMC Liposomes
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Figure 3-1 Interaction of varying concentrations of bromo iminosulfurane
derivative with DMPC liposomes in HEPES buffer with EDTA.
Data were fit by linear regression. Peaks shifts were referenced to an external
trimethylphosphate standard in HEPES buffer with EDTA (see the Materials and
Methods section 2.1.3).
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Figure 3-2 Plot of slopes of varying concentrations of bromo iminosulfurane
derivative of DMPC liposomes in HEPES buffer with EDTA.
Data were fit by linear regression. Peaks shifts were referenced to an external
trimethylphosphate standard in HEPES buffer with EDTA (see the Materials and
Methods section 2.1.3).
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3.1. Interaction of Varying Concentrations of Iodo Derivatives with DMPC
Liposomes
The decay of peak separation of varying concentrations of iodo iminosulfurane
derivative of DMPC liposomes in HEPES buffer with EDTA was plotted (Figure 33). The data were fit using second order polynomials. At 0.1 mole percent, the iodo
derivative appears to inhibit the reduction due to the normal aging as observed in the
control. In DMPC vesicles containing no cholesterol, concentrations of at least 1 mole
percent iodo derivative also decrease the 31P resonance separation, but at a rate that is
only marginally greater than that due to vesicle aging (Figure 3-3). Increasing the
concentration of the iodo derivative increases the decay of peak separation. However,
in contrast to the control, the peaks do not collapse to zero within 54 h, but reach a
plateau.
3.2. Summary of Interactions of Iminosulfurane Derivatives with DMPC
Liposomes at 10 mole Percent and 20 mole Percent
After 10 h, the 10 mole percent of the bromo derivative accelerates the decay of
peak separation. The peak separation versus time plot exhibits saturation when the
chloro or iodo TPE derivatives are present (Figures 3-3 and 3-4). The chloro
derivative appears to inhibit the reduction due to the normal aging as observed in the
control. The 31P peak separation corrected for the aging effect exhibits saturation 20
h after the bromo derivative has been added. The effect of the chloro and iodo
derivatives could not be distinguished from the aging effect in the control, TPE–free,
DMPC vesicles.
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Interaction of Varying Concentrations Iodo
Derivatives with DMPC Liposomes
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Figure 3-3 Interaction of varying concentrations of iodo iminosulfurane derivatives
with DMPC liposomes in HEPES buffer with EDTA.
Data fit using a 2nd order polynomial. Peaks shifts were referenced to an external
trimethylphosphate standard in HEPES buffer with EDTA (see the Materials and
Methods section).
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Interaction of Iminosulfurane Derivatives with
DMPC Liposomes
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Figure 3-4 Interaction of iminosulfurane derivatives with DMPC liposomes.
Data were fit using 2nd order polynomial. Peaks shifts were referenced to an external
trimethylphosphate standard in HEPES buffer (see the Materials and Methods section).
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3.3. Effect of Praseodymium Ion on DMPC Liposomes
Since the EDTA present in the HEPES buffer chelates a portion of the Pr3+,
removal of the EDTA requires significantly less shift reagent. A plot of shift reagent
versus 31P chemical shift separation between the inside and outside phosphate resonances
was fit with a 2nd order polynomial (Figure 3-5). Peak separation increases with an
increase in concentration of shift reagent, but approaches a maximum with 4.5 mM shift
reagent.

Results were similar to those observed with the addition of calcium and

lanthanum ions to outside of the phospholipid vesicles formed from egg
phosphatidylcholine.39 Hutton et al. also showed the effect praseodymium encapsulated
in the interior of the vesicles on peak separation. These titration curves were used to
determine inner and outer radii of lipid bilayers and had a similar shape as the curve in
Figure 3-5. Figure 3-6 shows the spectra of DMPC without EDTA in the buffer after the
addition of 0.90 mM Pr3+. The resonances from the inner and outer leaflet collapse within
25 h. After the addition of 1.35 mM Pr3+and 4.5 mM Pr3+, the resonances collapse within
33 h as shown in Figures 3-7 and 3-8, respectively. Decays of peak separation of DPMC
liposomes without EDTA in the buffer vary with different concentrations of Pr3+. The
data were fit with linear regressions (Figure 3-9). Increasing the shift reagent
concentration increased the rate of decay.
3.4. Effect of Bromo and Iodo Derivatives on DMPC Liposomes in Absence of
EDTA in the Buffer
Figure 3-8 shows the spectra of DMPC after the addition of 4.5 mM Pr3+ over
time. Spectrum (a) was obtained before the addition of shift reagent. Spectra (b-f) were
obtained in over a period of 42 h. The spectra in Figures 3-10 and 3-11 show the effect
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of 10 mole percent bromo iminosulfurane derivative and 10 mole percent iodo
iminosulfurane with DMPC liposomes in HEPES buffer, respectively. In spectrum (a)
are the phosphorus signals with no shift reagent. Spectra (b-j) illustrate the effect of the
appropriate derivative as a function of time. Peaks shifts were referenced to an external
trimethylphosphate standard in HEPES buffer (see the Materials and Methods section
2.1.3). The peak separations obtained from these spectra were plotted as a function of
time (Figure 3-13). The data were fit by a 2nd order polynomial. In DMPC vesicles
containing no cholesterol, the bromo derivative decreases the 31P resonance separation to
zero within 51 h, whereas the decrease in the peak separation caused by the presence of
the iodo derivative was more than half of its original value. The decay rates attributed to
the effect of the bromo and iodo derivatives were greater than in their absence.
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Figure 3-5 31P chemical shift separation between inside and outside phosphate
resonances versus the concentration of Pr 3+.
The data was fit with a 2nd order polynomial.
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Figure 3-6 Spectra of DMPC liposomes with 0.90 mM Pr3+.
Spectra (a-e) were obtained after the addition of 0.90 mM PrCl3. Peaks shifts were
referenced to an external trimethylphosphate standard in HEPES buffer (see the Materials
and Methods section 2.1.3).
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Figure 3-7 Spectra of DMPC liposomes with 1.35 mM Pr3+.
Spectra (a-d) were obtained after the addition of 1.35 mM PrCl3. Peaks shifts were
referenced to an external trimethylphosphate standard in HEPES buffer (see the Materials
and Methods section 2.1.3).
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Figure 3-8 Spectra of DMPC liposomes with no EDTA.
(a) is the phosphorus signal with no Pr3+. Spectra (b-f) were obtained after the addition of
4.5 mM PrCl3 Peaks shifts were referenced to an external trimethylphosphate standard in
HEPES buffer (see the Materials and Methods section 2.1.3).
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Decay of Peak Separation vs. Concentration of Shift Reagent
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Figure 3-9 The peak separation of DMPC decays in absence of iminosulfurane
derivatives at varying concentrations of Pr3+.
The data were fit by a linear regression.
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3.5. Comparisons of Decay Rates with DMPC Liposomes Containing Varying
Concentrations of Cholesterol
The

31

P NMR spectra were acquired for liposomes containing varying mole percent of

cholesterol, more specifically 8.8, 16, 27, and 35 as described in Material and Methods
section 2.1.3. Figures 3-13, 3-14, 3-15, and 3-16 show the spectra these liposomes
containing 8.8, 16, 27, and 35 mole percent of cholesterol, respectively. After the
addition of 0.45 mM of Pr 3+, the decay of peak separation was monitored over time. The
resonances associated with the inner and outer leaflet of liposomes containing 8.8 mole
percent collapsed to one peak within 25 h. The peak separation of liposomes containing
16 mole percent and 27 mole percent decreased to 5.5 ppm over 84 h and 8.97 ppm over
66 h respectively. The liposomes containing 35 mole percent cholesterol exhibited the
smallest decay of peak separation with resonances separated by 11 ppm after 92 h. The
stability of the liposomes varied with concentration of cholesterol as shown by Figure 317. The peak separations were plotted as a function of time for the different liposomes
preparations. The data from 8.8 and 16 mole percent were fit with a 2nd order polynomial,
whereas the data from 27 and 35 mole percent were fit with a 3rd order polynomial.
Increasing the concentration of cholesterol stabilizes the liposome, thereby minimizing
the decrease in peak separation over time.
3.6. 31P NMR of DMPC and 16 Mole Percent Cholesterol
Figure 3-7 shows the peak separation of DMPC liposomes containing 16 mole
percent cholesterol over time. Spectrum (a) is the

31

P resonance in absence of shift

reagent. Within minutes of the addition of the slowly penetrating shift reagent, the single
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phosphorus peak is split into two peaks, allowing for differentiation of the inner and outer
leaflet. However, maximum peak separation occurs within 18 h of the addition of
Pr3+(Spectra b-c).
Figure 3-8 shows the control which is the peak separation of DMPC liposomes
containing 16 mole percent cholesterol over time. Spectrum (a) is the resonance of the
phosphorus head group in absences of shift reagent. Within minutes of the addition of the
slowly penetrating shift reagent, the single phosphorus peak is split into two peaks
allowing for differentiation of the inner and outer leaflet. However, maximum peak
separation occurs within 18 h of the addition of Pr3+(Spectra b-d). The peak separation is
monitored over the next 66 h (Spectra e-n). After 84 h the peak separation decreases to
5.5 ppm.
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Figure 3-10 Spectra of DMPC liposomes with no EDTA after addition of 10 mole
Percent bromo compound.
(a) is phosphorus signal with no Pr3+. Spectra (b-n) were obtained after the addition of 4.5
mM PrCl3 Peaks shifts were referenced to an external trimethylphosphate standard in
HEPES buffer (see the Materials and Methods section 2.1.3).
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Figure 3-11 Spectra of DMPC Liposomes with no EDTA after addition of 10 mole
percent Iodo compound.
(a) is phosphorus signal with no Pr3+. Spectra (b-j) were obtained after the addition of
0.45 mM PrCl3 Peaks shifts were referenced to an external trimethylphosphate standard
in HEPES buffer; see the Materials and Methods section 2.1.3.
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Interaction of Bromo and Iodo Derivatives
with DMPC Liposomes without EDTA
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Figure 3-12 The effect of 10 mole percent bromo and iodo derivatives on 31P
resonances seen in DMPC liposomes without EDTA.
Data were fit with 2nd order polynomials.
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Figure 3-13 Spectra of DMPC liposomes with 8.8 mole percent cholesterol.
(a) is phosphorus signal with no Pr3+. Spectra (b-i) were obtained after the addition of 4.5
mM PrCl3 Peaks shifts were referenced to an external trimethylphosphate standard in
HEPES buffer (see the Materials and Methods section 2.1.3).
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Figure 3-13 DMPC and 16 mole percent cholesterol.
(a) is phosphorus signal with no Pr3+. Spectra (b-n) were obtained after the addition of
0.45 mM PrCl3 Peaks shifts were referenced to an external trimethylphosphate standard
in HEPES buffer (see the Materials and Methods section 2.1.3).
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Figure 3-14 Spectra of DMPC iposomes 27 mole percent cholesterol.
(a) is phosphorus signal with no Pr3+. Spectra (b-k) were obtained after the addition of
0.45 mM PrCl3 Peaks shifts were referenced to an external trimethylphosphate standard
in HEPES buffer (see the Materials and Methods section 2.1.3).
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Figure 3-15 Spectra of DMPC liposomes with 35 mole percent cholesterol.
(a) is phosphorus signal with no Pr3+. Spectra (b-n) were obtained after the addition of
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Decay of Peak Separation as a
Function of Cholesterol Concentration
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Figure 3-16 Decay of 31P resonance separation as a function of cholesterol
concentration.
8.8 mole percent cholesterol was fit with a 2nd order polynomial, whereas 16 mole
percent 27 mole percent and 35 mole percent were fit with a 3rd order polynomial.
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Figure 3-9 illustrates the spectra obtained from the interaction of 10 mole percent
bromo

derivative with DMPC containing 16 mole percent cholesterol.

After the

maximum peak separation between the inner and outer leaflet was achieved, 10 mole
percent bromo iminosulfurane was added (Figure 2.3-5). The effect of the bromo
derivative on the splitting was monitored as a function of time over a period of 66 h. In
DMPC vesicles containing 16 mole percent cholesterol, the addition of the bromo
derivative causes a collapse of the splitting to zero within 30 h.
Figure 3-10 illustrates the effect of the iodo derivative after the maximum peak
separation between the inner and outer leaflet was achieved (Spectra b-c). The effect of
the addition of 10 mole percent iodo iminosulfurane on the splitting was monitored as a
function of time over a period of 66 h. The addition of the iodo derivative causes a
collapse of the splitting to 2.5 ppm within 66 h.
The change in resonance separation in the presence of 10 mole percent chloro
derivative is plotted as a function of time in Figure 3-11. The reduction in the splitting
induced by the chloro derivative occurs over a longer period of time.
The change in resonance separation in the presence of 10 mole percent hydrogen
derivative is plotted as a function of time in Figure 3-12. The reduction in the splitting of
induced by the hydrogen derivative occurs over a longer period of time than that of
bromo and iodo derivatives.
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Figure 3-17 The interaction of praseodymium with DMPC and 16 mole percent
cholesterol.
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM
PrCl3. Spectra (c) is 18 h after the addition of 0.45 mM Pr3+.

3+

59

1.0

16%chol_10 Br.esp

0.5

l

50 h

k

44 h

j

37 h

i

30 h

h

23 h

g

18 h

f

12 h

e

4.8 h after addition of 10 mole % Bromo

0
-0.5

Normalized Intensity

-1.0
-1.5
-2.0
-2.5
-3.0
-3.5
-4.0
-4.5

d

18 h

c

12 h

b

4.8 h after addition of Pr

a

no Pr

-5.0

3+

3+

-5.5
20

15

10

5

0
-5
Chemical Shift (ppm)

-10

-15

-20

-25

-30

Figure 3-18 DMPC and 16 mole percent cholesterol with 10 mole percent bromo
derivative.
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after
the addition of 0.45 mM Pr3+. Spectra (e-l) were obtained after the addition of 10 mole
percent bromo derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts
were referenced to an external trimethylphosphate standard in HEPES buffer (see the
Materials and Methods section 2.1.3).
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Figure 3-19 DMPC and 16 mole percent cholesterol with 10 mole percent iodo
derivative.
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after
the addition of 0.45 mM Pr3+. Spectra (e-o) were obtained after the addition of 10 mole
percent iodo derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts
were referenced to an external trimethylphosphate standard in HEPES buffer (see the
Materials and Methods section 2.1.3).
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Figure 3-20 DMPC and 16 mole percent cholesterol with 10 mole percent chloro
derivative.
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after
the addition of 0.45 mM Pr3+. Spectra (e-o) were obtained after the addition of 10 mole
percent chloro derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts
were referenced to an external trimethylphosphate standard in HEPES buffer (see the
Materials and Methods section 2.1.3).
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Figure 3-21 DMPC and 16 mole percent cholesterol.
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after
the addition of 0.45 mM Pr3+. Spectra (e-p) were obtained after the addition of 10 mole
percent hydrogen derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks
shifts were referenced to an external trimethylphosphate standard in HEPES buffer (see
the Materials and Methods section 2.1.3).
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3.7. Summary Analysis of Iminosulfurane Derivatives with DMPC Liposomes
Containing 16 Mole Percent Cholesterol
The change in resonance separation in the absence of transdermal penetration
enhancers is plotted as a function of time in the control and demonstrates the effect of
these enhancers on the splitting of the 31P resonances associated with the inner and outer
leaflet of the vesicle bilayer. After 84 h, the resonances remain separated by 5 ppm in the
control spectrum. The addition of the bromo derivative causes a collapse of the splitting
to zero within 30 h as shown. The reduction in the splitting induced by the iodo, chloro,
and hydrogen derivatives occurs over longer periods of time, but at a rate that is only
marginally greater than that due to the control as shown in Figure 3-13. Lines drawn
through the data points were obtained by polynomial regression analyses.
3.8. Effect of 30 mole percent Cholesterol on DMPC Liposomes
Increasing the cholesterol content of the DMPC vesicles above 16 mole percent
further reduces the rate at which the splitting is collapsed by the iminosulfuranes. The
change in resonance separation in the absence of transdermal penetration enhancers is
plotted as a function of time in Figure 3-14. After 84 h, the resonances remain separated
by 5 ppm in the control spectrum.
The effect of the bromo derivative at 10 mole percent could not be distinguished from
the aging effect in the control. However, increasing the concentration of the bromo
derivative to 20 mole percent decreases the rate of 31P resonance separation greater than
that of the control.
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Interaction of Iminosulfurane Derivatives with
DMPC Liposomes Containing 16 Mole % Cholesterol
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Figure 3-22 Interaction of iminosulfurane derivatives with DMPC and 16 mole
percent cholesterol liposomes.
Data fit with polynomial fit. Peaks shifts were referenced to an external
trimethylphosphate standard in HEPES buffer (see the Materials and Methods section
2.1.3).
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Figure 3-23 DMPC and 30 mole percent cholesterol.
(a) is phosphorus signal with no Pr 3+. Spectra (b-n) were obtained after the addition of
0.45 mM PrCl3. Peaks shifts were referenced to an external trimethylphosphate standard
in HEPES buffer (see the Materials and Methods section 2.1.3).
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Figure 3-24 DMPC and 30 mole percent cholesterol interaction with bromo
derivative.
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after
the addition of 0.45 mM Pr3+. Spectra (e-q) were obtained after the addition of 10 mole
percent bromo derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts
were referenced to an external trimethylphosphate standard in HEPES buffer (see the
Materials and Methods section 2.1.3).
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Figure 3-25 DMPC and 30 mole percent cholesterol with 20 Percent bromo
derivative.
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after
the addition of 0.45 mM Pr3+. Spectra (f-r) were obtained after the addition of 20 mole
percent bromo derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts
were referenced to an external trimethylphosphate standard in HEPES buffer (see the
Materials and Methods section 2.1.3).
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Interaction of Bromo Derivatives with
DMPC liposomes containing 30 mole % cholesterol
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Figure 3-26 Interaction of bromo iminosulfurane derivatives with DMPC and 30
mole percent cholesterol liposomes with varying concentrations.
Data fit with polynomial fit. Peaks shifts were referenced to an external
trimethylphosphate standard in HEPES buffer(see the Materials and Methods section
2.1.3).
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Figure 3-27 DMPC and 30 mole percent cholesterol with addition of 10 percent iodo
derivative.
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after
the addition of 0.45 mM Pr3+. Spectra (e-o) were obtained after the addition of 10 mole
percent iodo derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts
were referenced to an external trimethylphosphate standard in HEPES buffer (see the
Materials and Methods section 2.1.3).
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Figure 3-28 DMPC and 30 mole percent cholesterol with 20 percent iodo
derivative.
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after
the addition of 0.45 mM Pr3+. Spectra (e-r) were obtained after the addition of 20 mole
percent iodo derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts
were referenced to an external trimethylphosphate standard in HEPES buffer (see the
Materials and Methods section 2.1.3).
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Interaction of Iodo Derivative with
DMPC liposomes containing 30 mole % cholesterol
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Figure 3-29 Interaction of different concentrations of iodo derivatives with DMPC
and 30 mole percent cholesterol liposomes.
Data were fit with 3rd order polynomial fit. Peaks shifts were referenced to an external
trimethylphosphate standard in HEPES buffer (see the Materials and Methods section
2.1.3).
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Figure 3-30 DMPC and 30 mole percent cholesterol with 10 mole percent chloro
derivative.
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after
the addition of 0.45 mM Pr3+. Spectra (f-r) were obtained after the addition of 10 mole
percent chloro derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts
were referenced to an external trimethylphosphate standard in HEPES buffer (see the
Materials and Methods section 2.1.3).

73

1

30%chol_20 Cl.esp

0

r
q

-1

p
o

84 h
77 h
71 h
64 h
57 h

n
Normalized Intensity

-2

50 h
44 h

m
l

-3

37 h
30 h
23 h
18 h

k
j

-4

i
h

-5

12 h
4.8 h after addition of 20 mole % Chloro

g
f

-6

23 h
18 h
12 h

e
d

-7

c
b

-8

4.8 h after addition of Pr
no Pr

a
20

15

10

5

0
-5
Chemical Shift (ppm)

-10

-15

3+

3+

-20

-25

-30

Figure 3-31 DMPC and 30 mole percent cholesterol with 20 mole percent chloro
derivative.
(a) is phosphorus signal with no Pr3+. Spectrum (b) is 4.8 h after the addition of 0.45 mM
PrCl3. Spectrum (c) is 12 h after the addition of 0.45 mM PrCl3. Spectra (d) is 18 h after
the addition of 0.45 mM Pr3+. Spectra (e-r) were obtained after the addition of 20 mole
percent chloro derivative after 0.45 mM PrCl3 had been added 18 h earlier. Peaks shifts
were referenced to an external trimethylphosphate standard in HEPES buffer (see the
Materials and Methods section 2.1.3).
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Interaction of Chloro Derivative with
DMPC Liposomes Containing 30 mole % Cholesterol
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Figure 3-32 Interaction of chloro iminosulfurane derivatives with DMPC and 30
mole percent cholesterol liposomes.
Data were fit with 3rd order polynomial. Peaks shifts were referenced to an external
trimethylphosphate standard in HEPES buffer (see the Materials and Methods section
2.1.3).
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Interaction of Iminosulfurane Derivatives with
DMPC Liposomes Containing 30 Mole % Cholesterol
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Figure 3-33 Interaction of iminosulfurane derivatives with DMPC and 30 mole
percent cholesterol liposomes.
Data were fit with 3rd order polynomial. Peaks shifts were referenced to an external
trimethylphosphate standard in HEPES buffer (see the Materials and Methods section
2.1.3).
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The effect of the iodo derivative at 10 mole percent could not be distinguished from the
aging effect in the control. However, increasing the concentration of the iodo derivative
to 20 mole percent decreased the rate of 31P resonance separation collapse greater than
that of the control.
3.9. Calibration Curve and Self Quenching of Carboxyfluorescein
Emission spectra of CF were measured at the λ

max ,

523 nm. Fluorescence of CF

is linear over the range 3-30 uM (data not shown). 38 A plot of concentration of CF versus
the fluorescence plotted outside of the linear region shows that at concentrations greater
than 3 mM, the fluorescence begins to quench. Figure 3-34 shows the decrease in
fluorescence as molar concentrations of CF exceed 3 mM. At 100 mM of CF,
fluorescence is 95 percent quenched and in excess of 200 mM, fluorescence is 97-98
percent quenched. 40
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Figure 3-34 Fluorescence of carboxyfluorescein as a function of concentration.
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3.10.

Stern-Volmer Plots of Bromo and Iodo Derivatives

Halogenated compounds such as iodine and bromine are known to exhibit the
heavy atom effect. The heavy atom effect causes the excited state of a fluorophore to be
deactivated by collisional quenching. As fluorophores in the excited singlet state collide
with halogenated compounds, their energy is transferred to the excited triplet state
through intersystem crossing.41 This process is defined by equation 3-1, which assumes
that there is only one class of fluorophores present and that they are equally accessible to
quenching.41 A plot of the ratio fluorescence in the absence of quencher to fluorescence
in the presence of quencher versus concentration has a y-intercept of one. The slope of
the line is the dynamic quenching constant.
To determine whether the aforementioned iminosulfuranes interfere with the
fluorescence of carboxyfluorescein, the change in fluorescence takes into account the
dilution effect that occurs upon addition of transdermal agents. Figures 3-25 and 3-26 are
the plots of the ratio fluorescence of CF in the absence of quencher to fluorescence of CF
in the presence of quencher versus concentration of quencher, where the quenchers are
the bromo compound and the iodo compound, respectively. The slope of the SternVolmer plot is 0.0028 µM

-1

for the bromo derivative and -0.00010 µM

-1

for the iodo

derivative; hence KD, the dynamic quenching constant is zero. The addition of varying
concentrations of quencher which is either the bromo compound or the iodo compound in
the micromolar quantities has no significant effect on fluorescence of CF.
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Fo
= 1 + KD[Q ] = 1 + kqτo [Q]
F
Equation 3-1 Stern-Volmer equation for collisional quenching.41
Fo is the fluorescence in absence of the quencher.
F is the fluorescence in the presence of the quencher.
KD is the Stern-Volmer quenching constant or dynamic quenching constant.
[Q] is the concentration of the quencher.
Kq is the bimolecular quenching constant.
τo is the lifetime of the fluorophore in absence of the quencher.
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Figure 3-35 Stern-Volmer plot for CF-bromo derivative system quenching of
carboxyfluorescein.
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1.4

1.2

1

y = -0.0001x + 0.9991

Fo/F

0.8

0.6

0.4

0.2

0
0

5

10

15

20

[Iodo Derivative] µM

Figure 3-36 Stern-Volmer plot for CF- iodo derivative system quenching of
carboxyfluorescein.
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3.11.

Structural Confirmation of Vesicles Encapsulated with CF

In order to monitor the vesicle preparation, electron micrographs were taken of
CF-free vesicles and vesicles encapsulated with CF. The CF-free vesicles have an
average diameter of 300 Å (Figure 3-38a), whereas the average diameter of vesicles
containing CF increases to 600 Å (Figure 3-38b). The encapsulation of CF doubles the
diameter of the vesicles. Similar results were observed with the encapsulation of
potential cyanine sensitive dyes into DMPC vesicles; where the vesicle diameter also
increased.37
3.12.

Carboxyfluorescein Release of DMPC Vesicles with Triton X-100

To test the effectiveness of a membrane disruptor, a fluorophore such as CF is
encapsulated in the interior of the vesicles at high concentrations. The fluorophore and
vesicle will be sonicated to encapsulate the dye. The sonicate will then be passed through
a chromatography column to remove the unencapsulated dye. Once the interior of the
vesicle contains the fluorophore in the appropriate concentration, the vesicles should
exhibit no fluorescence. Next the TPE can be applied to the vesicles. As the lipid bilayer
is disrupted, CF will leach out causing a measurable increase in fluorescence. The
increase in fluorescence is used to calculate the percent of CF released and provides a
measure on the effect of the membrane disruptor on the integrity of the bilayer.
Detergents are known disruptors of bilayers. When 8.5 mM Triton X-100, a
nonionic surfactant is added to the DMPC liposomes encapsulated with CF, the CF leaks
out over time and eventually all of the CF is released and quenching is relieved, causing
the amount fluorescence released to increase to 100 percent within 20 h (Figure3-39).
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3.13.

The Effect Iminosulfurane Derivatives on Bilayer Integrity Measured

by Carboxyfluorescein Release from DMPC Vesicles
The bromo derivative at 3.1, 6.1, and 16.1 mole percent was added to vesicles
encapsulated with CF and the resulting fluorescence of CF was monitored for 20 minutes
in one second intervals (Figure 3-40). The percentage of CF released was calculated the
according to equation 1-1. The maximum percent release was achieved within the time of
hand mixing. After the addition of iminosulfurane, the percent release of CF achieved a
maximum and decreases and reached a plateau. Addition of 3.1 percent bromo released
23 percent of CF. Doubling the amount of bromo to 6.1 percent caused the percentage of
CF released to be 39 percent, almost twice that achieved with 6.1 percent. The addition of
16.1 percent bromo released 61 percent of the encapsulated CF.
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(a)

(b)

Figure 3-37 Electron micrographs.
(a) is DMPC vesicles. The scale bar is 200 nm. (b) is CF encapsulated in DMPC vesicles.
The scale bar is 500 nm. For experimental conditions, see Material and Methods.
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Figure 3-38 Release of carboxyfluorescein in DMPC with addition of 8.5 mM Triton
X-100 as a function of time.
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3.14.
The Effect Bromo and Iodo Iminosulfurane Derivatives on Bilayer
Integrity Measured by Carboxyfluorescein Release from DMPC Vesicles
Containing 16 Mole Percent Cholesterol
The percent release of CF was monitored as a function of time in one second
intervals for 25 minutes (Figures 3-41 and 3-42). The maximum percent release were
achieved within the time of mixing. After the maximum release, the percent release of CF
decreases and reached a plateau. In the DMPC vesicles containing 16 mole percent
cholesterol, there was no CF release with the addition of 3.1 percent bromo derivative.
Doubling the amount of bromo derivative to 6.1

percent caused the release of

approximately 15 percent of CF. Thirty five percent of CF was released upon the addition
of 16 percent bromo derivative. The iodo derivative resulted in an increase of 8.9 percent
CF release when 3.5 percent iodo is added. Doubling the amount of iodo added increased
the amount of CF released to 25 percent. However, an increase of iodo to 19.1 percent
provided only a nominal increase in the percentage of CF released.
3.15.
The Effect Bromo and Iodo Iminosulfurane Derivatives on Bilayer
Integrity Measured by Carboxyfluorescein Release from DMPC Vesicles
Containing 30 Mole Percent Cholesterol
Vesicles containing 30 mole percent cholesterol were treated with varying
concentrations of bromo and iodo iminosulfuranes and monitored in one second intervals
for 25 minutes (Figures 3-43 and 3-44). The addition of 3.1 and 6.1 mole percent bromo
caused 23 percent and 31 percent CF to be released, respectively. The addition of 16.1
mole percent of bromo released 57 percent of the CF. Conversely, the addition of iodo
derivative releases less CF than the bromo derivative. The addition of 3.5 percent iodo
released 17 percent CF. Increasing the concentration from 7.0 mole percent to 19 mole
percent slightly increased the amount of CF released (from 27 percent to 32 percent).
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Figure 3-39 The percent of CF released as a function of Triton X-100 concentration.
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Figure 3-40 Percent changes in release of encapsulated carboxyfluorescein from
DMPC vesicles in the presence of increasing concentrations of bromo
iminosulfurane derivative.
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Figure 3-41 Percent changes in release of encapsulated carboxyfluorescein from
DMPC -16 mole percent cholesterol in the presence of increasing concentrations of
bromo derivative of iminosulfurane.
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Figure 3-42 Percent changes in release of encapsulated carboxyfluorescein from
DMPC -16 mole percent cholesterol vesicles in the presence of increasing
concentrations of iodo iminosulfurane derivative.
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Figure 3-43 Percent changes in release of encapsulated carboxyfluorescein from
DMPC -30 mole percent cholesterol vesicles in the presence of increasing
concentrations of bromo iminosulfurane derivative.
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Figure 3-44 Percent changes in release of encapsulated carboxyfluorescein from
DMPC -30 mole percent cholesterol in the presence of increasing concentrations of
iodo derivative of iminosulfurane.
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3.16. Summary of Carboxyfluorescein Release from Vesicles Containing Varying
Concentrations of Cholesterol with Bromo and Iodo Iminosulfuranes
Derivatives
Figure 3-45 illustrates the effect of the bromo and iodo derivatives on liposomes
containing different concentrations of cholesterol. Percentage of CF released increases
linearly with the concentration of bromo added in all of the observed DMPC
preparations, DMPC, DMPC with 16 mole percent cholesterol, and DMPC with 30 mole
percent cholesterol.

The greatest amount of CF is released in the DMPC vesicles

containing no cholesterol. The effect of increasing the amount of iodo in the cholesterol
preparations has a small effect on the percentage of CF released.
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Figure 3-45 Percent changes in release of encapsulated carboxyfluorescein from
liposomes in the presence of increasing concentrations of the bromo iminosulfurane
derivative
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Figure 3-46 Percent changes in release of encapsulated carboxyfluorescein from
DMPC - cholesterol liposomes in the presence of increasing concentrations of iodo
iminosulfurane derivative.

96

4. Discussion of Results
4.1. DMPC Bilayers Interactions with Iminosulfurane Measured by Calorimetry
Barrow et al. examine the effects of chloro, bromo and iodo iminosulfurane derivatives
on the two phase transitions of DMPC liposomes. During the first transition known as
pretransition phase, the polar headgroups are believed to reorient and the lipid bilayer
transitions from the gel to ripple layer organization. The main phase transition occurs
when the lipid organization changes from ripple to fluid.27 The pretransition peak
broadens and becomes part of the baseline in the presence of 10 mole percent
iminosulfurane derivatives. The disappearance of the pretransition peak could indicate
that the mode of action of the iminosulfuranes is a surface interaction. The main phase
transition occurs when the lipid organization changes from ripple to fluid. The bromo
derivative of the iminosulfurane caused a shoulder to appear before the main phase
transition of DMPC at a lower temperature. Since simulations of these data could not be
reproduced using a single two state model, a multi-two state model was used. This multitwo state model could be indicative of the formation of multiple melting domains and
consequently, the destabilization of the DMPC bilayer by the bromo derivative.27
Additionally when the concentration of the chloro derivative was one mole percent, the
profile was similar to the control. For the bromo and iodo derivatives, the profiles could
be fit to a single two state model. Therefore, it is possible that the perturbation of the
bilayer by iminosulfurane derivatives is concentration dependant.
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4.2. Evaluation of Bilayer Penetration of Lipid Bilayer using NOESY
Using the Nuclear Overhauser Effect Spectroscopy (NOESY), strong cross peaks were
found to exist between the phenyl protons of the iminosulfurane and the protons of the
unresolved methylenes in the DMPC hydrophobic tail. 27 Table 4-1 shows the cross peak
volumes as a function of the type of iminosulfurane derivatives at 10 mole percent. The
cross peak volume is largest for the most biologically active compound, the bromo
iminosulfurane. This observation suggests that there is a greater population of the bromo
derivative in the bilayer. The cross peak volume of the iodo derivative is less that than
that of the bromo derivative, which suggests that the iodo iminosulfurane does not
interact with the fatty acid portion of the bilayer to the extent that the bromo derivative
does.
Table 4-1 NOESY cross peak volumes of iminosulfurane derivatives.27

Substituent
H
Cl
I
Br

Cross Peak Volume
Methylene (mm3)
0
2.10
5.79
9.08

There are strong cross peaks between the N-methyl protons and the phenyl protons of
the bromo and iodo derivatives at 10 mole percent. However, the same cross peaks are
absent in the presence of 10 mole percent chloro derivative and one mole percent bromo
and iodo derivatives.27 These observations further support a concentration dependant
effect on bilayer perturbation. The most notable result of this series of experiments is the
appearance of a cross peak between the phenyl protons of the bromo derivative and the
terminal methyl of the lipid tail, which suggests that the bromo derivative is able to
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deeply penetrate into the bilayer.27 All NOESY measurements are based on the
assumption that the buildup rates are identical for all iminosulfuranes.27
4.3. Principles of 31P NMR
Some atomic nuclei have magnetic moments that are sensitive to their environment
and interact weakly with them. NMR exploits this propensity for dimagnetic nuclei such
as 1H, 2H, 13C, 14N, 19F and 31P to interact with magnetic fields. Because most molecules
contain at least one isotope with a magnetic moment, this interaction is useful for gaining
molecular information and kinetic information about molecules with little disruption on
the observed species.
When a magnetic nucleus, such as phosphorus is placed in a magnetic field, it adopts
one of two possible orientations. The nucleus should either be in the same direction as the
applied field (+½) or in the opposite direction of the applied field (-½). The nucleus has a
lower energy level when it is parallel to the field and a higher energy level when it is
antiparallel to the field. Sample magnetization from the NMR comes from the different
distribution of nuclear dipoles in the two energy states. Because the energy difference the
phosphorus nuclei is small, the population difference of energy levels is parts per million.
There are two ways in which NMR spectrum can be obtained, continuous wave and
pulse. Modern NMR spectroscopy employs pulse techniques. The data collected is in the
form of free induction decay (FID). Fourier transform converts the FID from time
domain into a spectrum in the frequency domain.
Phosphorus-31 has 100 percent natural abundance and a high gyromagnetic ratio
which makes it an ideal nucleus for probing the structure and interactions of lipids on a
microscopic level. Phosphorus peaks are typically characterized by broad lineshapes
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which are a result of the chemical shift anisotropy (CSA) due to limited phosphate group
motion in vesicles. Since chemical bonds are generally magnetically anisotropic, they
have different susceptibilities along the x, y, and z directions in space. Therefore, the
magnetic moments induced by the external field Bo are not uniform. The effect of CSA
can be minimized by the rotational diffusion of the molecule. Since the diffusional
motion and conformation of the head group can affect the CSA experienced by the
molecule, the lineshape of the phosphorus resonance is also a function of the motion and
conformation and provides information about the phase of lipids.42 The

31

P NMR

lineshapes most commonly found in lipid bilayers are characteristic of three types of
phases, isotropic, hexagonal and lamellar. The lineshape of lipids in the isotropic are
characterized by narrow sharp resonances. In the case of the phosphorus found in the
head group of small unilamellar vesicles (< 500 Å), the lineshape is narrow and sharp and
the result of the fast tumbling and diffusion rates relative to the NMR scale.43 The
lineshape characteristic of a hexagonal phase is asymmetric and has a slight shoulder on
the upfield from the peak. The characteristic lineshape of lamellar phases are also
asymmetric with a shoulder on the downfield of the resonance. Lipids in the lamellar
phase often transitioned to the hexagonal phase by increasing water content.32
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Figure 4-1 Characteristic 31P lineshapes.44-47
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At low magnetic field it is possible to observe the resonances from phosphorus in the
inner and outer leaflet. Since CSA increases with the square of the magnetic field
strength, at higher magnetic field, the peaks broaden so that the resonances of the inner
and outer leaflet become indistinguishable. In order to use a higher magnetic field and be
able to observe the resonances from the inner and outer leaflet, it becomes necessary to
use a shift reagent to split the resonances. Since phosphorus nuclei, like all magnetic
nuclei, are sensitive to their chemical environments, their sensitivity to chemical
surroundings can be exploited with the use of a lanthanide metal shift reagent which does
not significantly perturb the polar head group conformation.37 Pr3+ is a paramagnetic
species which interacts with the outer layer of the unilamellar vesicle via a pseudo
contact process (Figure 4-1).
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The pseudo contact process is an interaction that exists

between the magnetic dipole of the paramagnetic species and the phosphorus nuclei
(Equation 4-1). The resulting change in the resonance frequency is proportional to the
geometry (ν), and the magnetic dipole moment of the paramagnetic species (K). Contact
interaction varies inversely with the third power of distance (r). As a result, the shielding
of the phosphorus moiety in the head group in the outer leaflet is reduced and the
phosphorus group relaxes through an alternate pathway with a shortened relaxation time,
relative to that of a Pr3+ free control, which causes the peak of the outer leaflet to broaden
and shift downfield.
Hence, the 31P resonances of DMPC and DMPC-cholesterol unilamellar vesicles are
split into two signals by the slowly penetrating paramagnetic metal ion Pr3+. The extent to
which this splitting is attenuated by transdermal penetration enhancers is indicative of the
extent to which such deep penetration has occurred and has been investigated as a
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function of the time over which the DMPC and DMPC-cholesterol preparations are
exposed to Pr3+ utilizing the iminosulfuranes described in Figure 1-4.
The extent of the iminosulfurane-induced perturbation of the bilayer preparations can
be observed over time as a reduction in the Pr3+ - mediated 31P resonance separation. As
the iminosulfurane-induced perturbation of the bilayer develops, the collapse of the

31

P

resonances suggests that Pr3+ is gaining access to the phosphate groups on the inner
leaflet on a short distance scale since the contact interaction varies inversely with the
third power of the distance between the phosphorus moiety and the paramagnetic species
(Equation 4-1). This observation confirms that the perturbation induced by these
iminosulfuranes extends to an appreciable extent across the bilayer, i.e. it is a
transmembrane effect and implies deep penetration of these compounds into the bilayer.

3cos2 υ − 1
∆ Dip = K
r3
Equation 4-1 Pseudocontact term.48
∆Dip is shift in resonance frequency.
K is constant that depends on the magnetic dipole moment of the paramagnetic ion.
υ is the angle between the paramagnetic ligand and the observed nuclei.
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Figure 4-2 Interaction of phosphorus nuclei with praseodymium shift reagent.48
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4.4. Evaluation of Iminosulfurane Activity Using 31P NMR
In the DMPC vesicle system prepared in HEPES buffer with EDTA, concentrations
of bromo and iodo iminosulfuranes below 1 mole percent actually impede the collapse of
peak separation relative to the control suggesting that perhaps there is a threshold
concentration at which the bromo derivative becomes active similar to DMSO which is
most effective at 60 percent. Five mole percent bromo compound provides a marginal
increase in decay. However, it is within the limits of error for the control. Ten mole
percent bromo provides a significant increase in the decay of resonance peak separation
relative to the control. The peak collapses completely to zero which indicates that in the
presence of 10 mole percent bromo, the Pr 3+ is able to gain access to the inner leaflet of
the bilayer.

4.5. Effect of Concentration Dependence on Iminosulfurane Activity Using
NMR

31

P

In the DMPC vesicles suspended with HEPES buffer containing EDTA,
iminosulfurane concentrations below 1 mole percent may actually impede the collapse of
peak separation relative to the control suggesting that perhaps there is a threshold
concentration at which the bromo derivative is able to perturb the bilayer. This
observation is also supported by the DSC heat profiles and NOESY cross peak reported
by Barrow et al.27 The concentration dependence of efficacy is also a characteristic of
DMSO which has a threshold concentration at which it is most effective.25 Five mole
percent bromo compound provides a marginal increase in decay. However, it is within
the limits of error for the control. Ten mole percent bromo provides a significant increase
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in the decay of resonance peak separation relative to the control. The peak collapses
completely to zero, which suggests that in the presence of 10 mole percent bromo, the
Pr3+ is able to gain access to the inner leaflet of the bilayer.
One tenth of a percent of iodo derivative seems to have a stabilizing effect on the
collapse of peak separation, whereas one percent has no effect on the decrease in peak
separation. Ten mole percent iodo collapses the peak separation to 6 ppm with in 30
hours. At this concentration, the iodo peak separation does not reach zero. Therefore the
iodo compound causes less of a bilayer disruption.
Comparison of the bromo, iodo, and chloro derivatives at 10 mole percent, 10 mole
percent, and 20 mole percent, respectively, support the biological data that the bromo
compound is the most active. Additionally, 10 mole percent of bromo caused the collapse
of peaks within 50 hours.
These results correlate with the NOESY cross peak data and permeation studies
(Figures 4-3 and 4-4). Based on the biological activities of the halogenated
iminosulfuranes, the bromo derivative is the most active, followed by the iodo derivative
and finally by the chloro derivative, the least active of the series (Figures 4-3).
Slowly penetrating paramagnetic metal ions differentially shorten the relaxation time
of the phosphate moieties in the inner and outer leaflets of the lipid bilayers.39 This
observation further suggests that a perturbation of sufficient extent to accommodate the
passage of the hydrated form of the Pr3+ is probably developed (i.e., a water channel is
induced by the iminosulfuranes in order for the highly charged ion to gain access to the
phosphorus moiety in the inner leaflet of the membrane bilayer).
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4.6. Effect of Praseodymium Ion on DMPC Liposomes
Since phosphate groups are binding sites for positive metal ions, each vesicle has a
fixed number of binding sites.

39

Assuming that all phosphate groups in the outer leaflet

of the bilayer are equally accessible, an increasing metal concentration will eventually
saturate the available binding sites and cause the peak separation between the inner and
outer leaflets to reach a maximum.

It is possible that as the Pr3+ concentration

approaches 4.5 mM, the peak separation approaches a maximum because the sites
approach maximum capacity.
Increasing the concentration of Pr3+ results in an increase of peak separation between
the inner and outer leaflet of the lipid bilayer, because the amount of shielding
experienced by the phosphate groups in the outer leaflet of the bilayer is greater than that
of the inner leaflet. As result of the shielding, resonances due to the phosphate groups on
the outer leaflet shift downfield and broaden. Since the increased concentration of shift
reagent does not alter the time that it takes for the two resonances to collapse into one
peak, the peak separation decay rate increases with increasing concentrations.
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Figure 4-3 Comparison of inverse peak separation and Q24, a measure of biological
activity of the iminosulfuranes.
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Figure 4-4 Comparison of inverse peak separation and cross peak volumes
measured with the NOESY DMPC vesicles and iminosulfurane derivatives.
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4.7. Interaction of Bromo and Iodo Iminosulfuranes with DMPC Liposomes
In DMPC liposome suspended in HEPES with no EDTA, there is an appearance
of third peak 16 hours after the addition of shift reagent. Since phosphate lineshapes
are indicative of a polymorphism of the lipid bilayers, the appearance of an additional
spectral component indicates that the phosphate group is in a different orientation
therefore experiencing a different magnetic moment from what is normally found in
lipids. 49 This spectral components supports the notion that there is a transition of the
lipid from a bilayer to hexagonal phase, a change that most probably the results from
movement of the Pr3+ ion across the bilayer.49 Within the 6 hours, the additional
spectral component disappears and the spectra once again become typical for lipid
bilayer phases. The shift reagent therefore induces a transient change in phosphate
head group conformation.50 The effect of 10 mole % of iminosulfuranes, bromo and
iodo derivatives, on DMPC liposome further supports the biological data and NOESY
cross peak volumes discussed in sections 1-3 and 4-2, respectively. The peak
separation of the inner and outer leaflet of the bilayer collapse to zero within 52
hours. This complete collapse supports the theory that the bromo derivative induces
the formation of a pore or channel that allows the praseodymium ion to move through
the bilayer and shield the phosphate groups in the inner leaflet. Conversely, the effect
of the iodo has a smaller effect on the collapse of peak separation. During the time of
the experiment, the peak separation decreased from 15 ppm to 8 ppm within 64 hours.
While the iodo derivative is active, it is not as active as the bromo compound.
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4.8. Decay of 31P Resonance Separation as a Function of Cholesterol
Concentration
It has been suggested that cholesterol induces a new state that is different from the gel
state or the liquid-crystalline state. The new state is referred to as the liquid ordered
state.33 The presence of the rigid steroid nucleus of cholesterol inserts itself into bilayer
reducing the number of kinks in the hydrophobic tail of the lipids.33 The reduction of
kinks in lipids containing less than 18 carbons causes the membrane to thicken. In
addition to these morphological changes, cholesterol decreases the permeability of small
molecules across the membrane bilayer. Normally small molecules are able to permeate
the membrane via transient channels in the bilayer that result from lipids packing
defects.33 The ordering of the bilayer by cholesterol minimizes these packing defects.
Consequently, the permeability of small molecules decreases with increasing cholesterol
content. Finally, the cholesterol interferes with the electrostatic interactions and hydrogen
bonds that form between phosphate head groups.33
The decays of

31

P resonances were monitored as a function of cholesterol

concentration. The most obvious change that occurred was the increased stability of the
system as a result of the increased cholesterol concentration. The time needed for the
Pr3+ ion to gain access to the inner leaflet increased with greater cholesterol
concentration. This observation is supported by the fact that cholesterol reduces the
permeability of small molecules. The time required for the liposomes to achieve
maximum peak separation at constant shift reagent concentration was directly
proportional to the cholesterol concentration. It may be that the interference of
cholesterol with head group interaction alters the time needed for the Pr3+ ion to bind to
phosphate groups.
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4.9. Effect of Iminosulfurane on Liposomes Containing 16 Mole Percent
Cholesterol
The effect of bromo, iodo, chloro, and hydrogen derivatives on splitting was
monitored as a function of time over a period of 90 hours in DMPC vesicles containing
16 mole percent cholesterol. The addition of the bromo derivative caused a collapse of
the splitting to zero within 30 h and broadened the lineshape of the resonance of the outer
leaflet. The collapse of peak separation within 30 hours suggests that the 10 mole percent
bromo induces a change in the bilayer such that the permeability of the praseodymium
ion is increased relative to that experienced by the control. The characteristic line
broadening has been suggested to be a consequence of the action of membrane active
agents.49 The line broadening in this region is explained by idea that part of the lipid
bilayer is immobilized and disorganized by the presence of a membrane active compound
such as the bromo derivative of the iminosulfurane. Yet it remains in equilibrium with the
bilayer.49 Both observations of the bromo derivative support the findings discussed
earlier. Biological data as well as NOESY cross peak volumes and DSC heat profiles
indicate that activity of the bromo compound is a function of deep penetration into the
bilayer and the formation of pores or channels that allow small molecules to move across
the membrane.
Ten mole percent of the iodo compound is less active than the bromo, an observation
that confirms biological data. However based on the decay of peak separations, the iodo
compound perturbs the bilayer more than the chloro and hydrogen derivatives.
Examination of the peak shapes after the addition of iodo derivative and comparison to
the chloro and hydrogen derivatives clearly shows that there is a greater perturbation
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caused by the iodo compound. The activity of the chloro and hydrogen derivatives is
minimal in contrast to that of the bromo and iodo derivatives.
4.10. Effect of Iminosulfurane on Liposomes Containing 30 Mole Percent
Cholesterol
The effect of iminosulfurane derivatives on the peak separation was monitored as a
function of time over a period of 90 hours in DMPC vesicles containing 30 mole percent
cholesterol. The addition of iminosulfurane derivatives at 10 and 20 mole percent caused
a collapse of the splitting that was not significantly different from the control. This
observation is a consequence of the ordering and reduced permeability of the membrane
bilayer caused by the incorporation of cholesterol into the membrane. However upon
close examination of the spectra of the bromo and iodo derivatives at 10 and 20 mole
percents (Figures 3-24, 3-25, 3-27 and 3-28), there is a difference in the linewidths of the
resonance due to the inner leaflet when compared to that from the control. The bromo and
iodo derivatives perturb the bilayer to a greater extent than that of the either the chloro or
hydrogen derivatives as shown by examination of the spectra.
4.11. Principles of Fluorescence
Fluorescence is one of the types of molecular luminescence spectroscopy that occurs
when a photon of light is absorbed. The absorbed photons are then emitted in one of two
ways. The first type of emission is known as resonance fluorescence where the absorbed
and emitted photon has the same energy or wavelength. The second type is observed
more often and results from a Stokes’ shift which occurs when the emitted photon has a
longer wavelength or is less energetic than the absorbed photon.
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In fluorescence, an electron is excited at a particular wavelength. The excited electron
moves from the ground state (So) to a vibrational level in the singlet state through a
nonradiative process. A photon is emitted as the electron falls from the singlet state to the
ground state (Figure 4-5). The amount of time required for the emission is greater than
the time required for absorption. However, when compared to phosphorescence, which
involves a forbidden transition, spin flip inversion, the lifetime for fluorescence is
relatively short, picoseconds to nanoseconds.
There are many processes that compete with fluorescence, for example: internal
conversion, predissociation, external conversion, and intersystem crossing.

Internal

conversion occurs when the absorbed photon goes to a lower electronic energy state
nonradiatively. Predissociation and dissociation occur with the rupture of a molecular
bond and chromophore, respectively. External conversion is a function of the
environment, because energy transfer between the species, solvent and other surrounding
molecules can deactivate the excited state. Intersystem crossing is a forbidden process,
but it does occur when the electron relaxes from an excited singlet to a triplet and
undergoes spin flip inversion. Despite these competing processes, a molecule that
fluoresces has several advantages over a molecule that can only be detected by absorption
spectroscopy. Fluorescence is particularly useful because the linear concentration range is
greater and more sensitive than absorption spectroscopy.
4.12. Selection of Fluorophore
Lipids are devoid of intrinsic fluorescence. Therefore, in order to examine the
effect of iminosulfuranes on membrane integrity using fluorescence, it becomes
necessary to use an extrinsic fluorophore. An ideal fluorophore for this system must not
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bind to the membrane, must undergo self quenching, have a small Stokes shift, and
absorb in the far red region. Several classes of fluorophores were considered: e.g.,
fluorescein analogs, cyanines, rhodamines, xanathamide fluorescent dyes, fluorescent
sterols, and styryls. Cyanines, rhodamines, xanathamide, fluorescent dyes, fluorescent
sterols, and styryls tend to bind or anchor to the lipid bilayers, whereas
carboxyfluorescein has very little association with membranes. 51-56
The ideal fluorophore should exhibit a small Stokes Shift, the difference in the
wavelength between absorbed and emitted quanta (Figure 4-6). The emitted wavelength
is equal to or longer than the excitation wavelength. Small overlap of excitation and
emission spectra will permit the fluorescence of the dye to be self-quenched at high
concentrations such as could exist in the interior of a vesicle. Self- quenching occurs
when there is a large number of species in solution, resulting in collisions between
molecules. These collisions cause a radiationless energy transfer. The efficiency of which
varies inversely with sixth power of the distance between two molecules of the
fluorophore. This radiationless transfer competes with the fluorescence and hence lowers
the quantum yield of fluorescing species at high concentrations. The structure of
carboxyfluorescein is shown in Figure 4-7. It is an ideal fluorophore for this assay in that
it exhibits minimal association with lipid bilayers, undergoes self-quenching at
concentrations greater than 100 mM via the formation of dimers (Figure 4-8) and absorbs
in the far red region of the visible spectrum
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4.13. Structural Characterization of Vesicles Encapsulated with CF
The increase in the diameter of the vesicles encapsulated with CF raises the question
as to why the presence of the dye shifts the diameter to a larger size (Figure 3-37). There
were two possible considerations that could account for the shift. The possibilities are
the osmotic swelling of the vesicles or fusion of two or more vesicles.37 Bammel et al.
used electron micrographs and T2 relaxation time NMR experiments to determine the
phenomena responsible for these observations. Electron micrographs showed that vesicle
fusion continues until all of the vesicles aggregated while there was no minimal
concentration necessary for the decrease in T2 relaxation times.37 Based on these results,
it was inferred that vesicle fusion is principally responsible for the increase in diameter.37
4.14. Stern-Volmer Plots of Bromo and Iodo Derivatives
The heavy atom effect of halogenated compounds is an important consideration for
the use of halogenated iminosulfuranes in an assay measuring fluorescence. The SternVolmer plots of the bromo and iodo derivatives had a slope of zero when the
concentrations of the compounds were in the micromolar range, indicating that the
diffusional quenching constant is zero. Consequently, there is no heavy atom effect
exhibited by these compounds in the micromolar range.
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Figure 4-6 Excitation and emission spectra of carboxyfluorescein.57
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119

high concentrations

CF

+

CF

CF

CF

nonfluorescent dimer

Figure 4-8 Quenching of carboxyfluorescein at concentrations greater than 100 mM.
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4.15. Interaction of Triton X-100 on Bilayer Integrity
The CF release curve exhibited an increase in CF release until a plateau was reached,
when 100 percent of the CF had been released. It has been suggested that nonionic
surfactant monomers incorporate into the bilayer to induce pore formation or stabilize
transient pores.58-60 The plateau is achieved when all of the CF has been released.
Nonionic surfactants are effective TPEs. Understanding the behavior of Triton X-100 is
important 20 percent (v/v) Triton X-100 is added the ended of the CF quenching assay in
order to determine the maximum fluorescence intensity (Equation 4-1).
4.16. Bilayer Integrity Measured by Carboxyfluorescein Release from DMPC
Vesicles and DMPC Vesicles with Cholesterol
The objective of this assay was to determine the effect of iminosulfurane
derivatives on the bilayer integrity of vesicles. All CF release curves decrease
exponentially where the maximum amount of CF is released within the time of mixing
the sample. The amount of CF released increases linearly with increased concentrations
of bromo derivative. It is likely that the bromo derivative induces the formation of
channels in the membrane bilayer by interacting with the polar head groups of the lipid
matrix and displacing surrounding water molecules similar to DMSO.

The iodo

derivative causes a CF release that is much smaller than that induced by the bromo
derivative. These results are supported by the reported biological activity, where the
bromo derivative is the most active in the series of compound.26 These results are further
supported by the observation of the effect of these transdermal penetration enhancers on
the decay of peak separation in the

31

P NMR experiments. In the presence of bromo
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derivative, the Pr3+ was able to gain access to the inner leaflet more quickly than the time
required to gain access in the presence of the iodo derivative.
4.17. Summary of Interactions of Iminosulfurane Derivatives
The bromo derivative is the most active iminosulfurane in this series of
compounds followed by the iodo and chloro derivatives.26 The time course of the
collapse of the 31P NMR resonance correlates with this activity in that the splitting is
collapsed most rapidly by the bromo derivative as shown in DMPC and DMPC/ 16
mole percent cholesterol models. The collapse of the two phosphorus peaks indicates
that the Pr3+ is able to gain access to the both the outer and inner leaflets on a time
scale of hours. The collapse of the Pr3+ -split

31

P resonances in the presence of

iminosulfuranes occurs significantly faster than in their absence. This critical
observation is highly supportive of a mode of action dependent on the deep
penetration of these iminosulfuranes into the bilayer, but surface interaction with the
lipids also remains a complementary mechanism for the activity of these transdermal
penetration enhancers.
Furthermore, the effect of these molecules on bilayer integrity can be seen with a
carboxyfluorescein release assay. Results based on the TPE-induced release of
carboxyfluorescein trapped in the internal volume of DMPC vesicles further indicate
that these iminosulfuranes disrupt the bilayer sufficiently to allow for the release of
the fluorophore. The addition of the bromo derivative, the most active compound,
causes a greater release in CF than that caused by the iodo derivative.
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4.18. Mechanism of Action of Halogenated Iminosulfuranes
The mechanism of action supported by the results summarized suggest the active
iminosulfuranes may act by penetrating the bilayer and inducing channels or pores in the
membrane that allow for the movement of small molecules across the bilayer in the
presence and absence of cholesterol. The incorporation of cholesterol at 16 mole percent
stabilized the lipid bilayer and made it easier to see the effect of the iminosulfurane
derivatives, whereas 30 mole percent cholesterol almost completely sealed the bilayer so
that was the difference between the types and concentrations of iminosulfuranes were
almost indistinguishable. The differential in the TPE activity of the bromo in contrast to
that of the other three derivatives may be a result of enhanced residence time of the
bromo derivative in the bilayer.
4.19. Further Studies on Halogenated Iminosulfuranes
The overarching question that needs to be answered is why the bromo derivative is the
most active in this series of halogenated iminosulfuranes. Based solely on
electronegativity, the expectation would be that the fluoro derivative would be the most
biologically active. However, the fluoro derivative is biologically inactive. In contrast,
comparison of relative size would support the iodo derivative being the most biologically
active in this series. Since the neither the fluoro derivative or the iodo derivative are the
most active, there must be other physico-chemical considerations that make the bromo
derivative the most effective transdermal penetration enhancer. Perhaps, the bromo
derivative has more available binding sites on the bilayer than the other derivatives which
would cause an appreciable increase in the amount of channels induced in the DMPC
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membrane. As a result, the number of channels induced in the membrane would be
directly proportional to the amount of drug able to permeate the lipid matrix of the skin.
Binding studies and scatchard analysis of iminosulfurane derivatives present in different
concentrations may provide further insight into the increased efficacy of the bromo
derivative relative to the other halogenated iminosulfuranes. The great extent to which
the bromo derivative perturbs the bilayer may also be a function of the nature of the
halogen

oxygen

bonds

that

may

form

with

the

iminosulfurane

derivative.

Characterization and comparison of these bonds may further support the biological
activity of this series of iminosulfuranes.
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